Erratum: Influenza Virus Targets Class i MHC-Educated NK Cells for Immunoevasion (PLoS Pathogens (2016) 12:2 (e1005446) DOI: 10.1371/journal.ppat.1005446);Influenza Virus Targets Class I MHC-Educated NK Cells for Immunoevasion

PLoS Pathogens

Volumn 12, Issue 2, 2016, Pages

  Mahmoud, Ahmad Bakur ^a,b   Tu, Megan M ^b   Wight, Andrew ^b   Zein, Haggag S ^b,c   Rahim, Mir Munir A ^b   Lee, Seung Hwan ^b   Sekhon, Harman S ^d   Brown, Earl G ^b   Makrigiannis, Andrew P ^b,e  

^a TAIBAH UNIVERSITY   (Saudi Arabia)

^b UNIVERSITY OF OTTAWA   (Canada)

^c CAIRO UNIVERSITY   (Egypt)

^d UNIVERSITY OF OTTAWA   (Canada)

^e DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY A; PERFORIN; BETA 2 MICROGLOBULIN; LY ANTIGEN; PERFORIN, MOUSE; PORE FORMING CYTOTOXIC PROTEIN;

ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN BINDING; ANTIVIRAL ACTIVITY; ARTICLE; BODY WEIGHT; CELL MATURATION; CONTROLLED STUDY; DISEASE PREDISPOSITION; FLOW CYTOMETRY; HISTOPATHOLOGY; HOST RESISTANCE; IMMUNE EVASION; IMMUNE RESPONSE; IMMUNOPATHOLOGY; INFLUENZA; INFLUENZA VIRUS; MOUSE; NATURAL KILLER CELL; NONHUMAN; PLAQUE ASSAY; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; VIRUS LOAD; VIRUS PATHOGENESIS; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL CULTURE; COCULTURE; CROSS BREEDING; GENETICS; GERMFREE ANIMAL; IMMUNOLOGY; INFLUENZA A VIRUS; INNATE IMMUNITY; KNOCKOUT MOUSE; LUNG; METABOLISM; ORTHOMYXOVIRUS INFECTION; PATHOLOGY; PHYSIOLOGY; RESPIRATORY MUCOSA; SURVIVAL ANALYSIS; TRANSGENIC MOUSE; TUMOR CELL LINE; VIROLOGY;

ANIMALS; ANTIGENS, LY; BETA 2-MICROGLOBULIN; CELL LINE, TUMOR; CELLS, CULTURED; COCULTURE TECHNIQUES; CROSSES, GENETIC; IMMUNE EVASION; IMMUNITY, INNATE; INFLUENZA A VIRUS; KILLER CELLS, NATURAL; LUNG; MICE, KNOCKOUT; MICE, TRANSGENIC; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY A; ORTHOMYXOVIRIDAE INFECTIONS; PORE FORMING CYTOTOXIC PROTEINS; RECEPTORS, KIR; RESPIRATORY MUCOSA; SPECIFIC PATHOGEN-FREE ORGANISMS; SURVIVAL ANALYSIS;

EID: 84959476337     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1006105     Document Type: Erratum

References (44)

1. Kuiken T, Holmes EC, McCauley J, Rimmelzwaan GF, Williams CS, Grenfell BT, Host species barriers to influenza virus infections. Science. 2006Apr21;312(5772):394–7. 16627737
2. Medina RA, Garcia-Sastre A, Influenza A viruses: new research developments. Nat Rev Microbiol. 2011Jul11;9(8):590–603. doi: 10.1038/nrmicro261321747392
3. World Health OrganizationInfluenza (seasonal). March2014.
4. White MR, Doss M, Boland P, Tecle T, Hartshorn KL, Innate immunity to influenza virus: implications for future therapy. Expert Rev Clin Immunol. 2008Jul1;4(4):497–514. 19756245
5. Jost S, Altfeld M, Control of human viral infections by natural killer cells. Annu Rev Immunol. 2013;31:163–94. doi: 10.1146/annurev-immunol-032712-10000123298212
6. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S, Functions of natural killer cells. Nat Immunol. 2008May;9(5):503–10. doi: 10.1038/ni158218425107
7. Forberg H, Hauge AG, Valheim M, Garcon F, Nunez A, Gerner W, et al. Early responses of natural killer cells in pigs experimentally infected with 2009 pandemic H1N1 influenza A virus. PLoS One. 2014Jun23;9(6):e100619. doi: 10.1371/journal.pone.010061924955764
8. Jansen CA, de Geus ED, van Haarlem DA, van de Haar PM, Londt BZ, Graham SP, et al. Differential lung NK cell responses in avian influenza virus infected chickens correlate with pathogenicity. Sci Rep. 2013;3:2478. doi: 10.1038/srep0247823963354
9. Anfossi N, Andre P, Guia S, Falk CS, Roetynck S, Stewart CA, et al. Human NK cell education by inhibitory receptors for MHC class I. Immunity. 2006Aug;25(2):331–42. 16901727
10. Dam J, Guan R, Natarajan K, Dimasi N, Chlewicki LK, Kranz DM, et al. Variable MHC class I engagement by Ly49 natural killer cell receptors demonstrated by the crystal structure of Ly49C bound to H-2K(b). Nat Immunol. 2003Dec;4(12):1213–22. 14595439
11. Achdout H, Manaster I, Mandelboim O, Influenza virus infection augments NK cell inhibition through reorganization of major histocompatibility complex class I proteins. J Virol. 2008Aug;82(16):8030–7. doi: 10.1128/JVI.00870-0818524833
12. Achdout H, Arnon TI, Markel G, Gonen-Gross T, Katz G, Lieberman N, et al. Enhanced recognition of human NK receptors after influenza virus infection. J Immunol. 2003Jul15;171(2):915–23. 12847262
13. Yokoyama WM, Plougastel BF, Immune functions encoded by the natural killer gene complex. Nat Rev Immunol. 2003Apr;3(4):304–16. 12669021
14. Long EO, Kim HS, Liu D, Peterson ME, Rajagopalan S, Controlling natural killer cell responses: integration of signals for activation and inhibition. Annu Rev Immunol. 2013;31:227–58. doi: 10.1146/annurev-immunol-020711-07500523516982
15. Yokoyama WM, Plougastel BF, Immune functions encoded by the natural killer gene complex. Nat Rev Immunol. 2003Apr;3(4):304–16. 12669021
16. Parham P, MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol. 2005Mar;5(3):201–14. 15719024
17. Rahim MM, Tu MM, Mahmoud AB, Wight A, Abou-Samra E, Lima PD, et al. Ly49 receptors: innate and adaptive immune paradigms. Front Immunol. 2014Apr2;5:145. doi: 10.3389/fimmu.2014.0014524765094
18. Kim S, Poursine-Laurent J, Truscott SM, Lybarger L, Song YJ, Yang L, et al. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature. 2005Aug4;436(7051):709–13. 16079848
19. Choi T, Ferris ST, Matsumoto N, Poursine-Laurent J, Yokoyama WM, Ly49-dependent NK cell licensing and effector inhibition involve the same interaction site on MHC ligands. J Immunol. 2011Apr1;186(7):3911–7. doi: 10.4049/jimmunol.100416821335486
20. Belanger S, Tu MM, Rahim MM, Mahmoud AB, Patel R, Tai LH, et al. Impaired natural killer cell self-education and "missing-self" responses in Ly49-deficient mice. Blood. 2012Jul19;120(3):592–602. doi: 10.1182/blood-2012-02-40873222661698
21. Liao NS, Bix M, Zijlstra M, Jaenisch R, Raulet D, MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity. Science. 1991Jul12;253(5016):199–202. 1853205
22. Tu MM, Mahmoud AB, Wight A, Mottashed A, Belanger S, Rahim MM, et al. Ly49 family receptors are required for cancer immunosurveillance mediated by natural killer cells. Cancer Res. 2014Jul15;74(14):3684–94. doi: 10.1158/0008-5472.CAN-13-302124802191
23. Luetke-Eversloh M, Killig M, Romagnani C, Signatures of human NK cell development and terminal differentiation. Front Immunol. 2013Dec30;4:499. doi: 10.3389/fimmu.2013.0049924416035
24. Raulet DH, Missing self recognition and self tolerance of natural killer (NK) cells. Semin Immunol. 2006Jun;18(3):145–50. 16740393
25. Ortaldo JR, Mason AT, Winkler-Pickett R, Raziuddin A, Murphy WJ, Mason LH, Ly-49 receptor expression and functional analysis in multiple mouse strains. J Leukoc Biol. 1999Sep;66(3):512–20. 10496323
26. Tay CH, Welsh RM, Brutkiewicz RR, NK cell response to viral infections in beta 2-microglobulin-deficient mice. J Immunol. 1995Jan15;154(2):780–9. 7529286
27. Polic B, Jonjic S, Pavic I, Crnkovic I, Zorica I, Hengel H, et al. Lack of MHC class I complex expression has no effect on spread and control of cytomegalovirus infection in vivo. J Gen Virol. 1996Feb;77 (Pt 2) (Pt 2):217–25. 8627225
28. Orr MT, Murphy WJ, Lanier LL, 'Unlicensed' natural killer cells dominate the response to cytomegalovirus infection. Nat Immunol. 2010Apr;11(4):321–7. doi: 10.1038/ni.184920190757
29. Rahim MM, Tai LH, Troke AD, Mahmoud AB, Abou-Samra E, Roy JG, et al. Ly49Q positively regulates type I IFN production by plasmacytoid dendritic cells in an immunoreceptor tyrosine-based inhibitory motif-dependent manner. J Immunol. 2013Apr15;190(8):3994–4004. doi: 10.4049/jimmunol.120087323479228
30. Brown EG, Increased virulence of a mouse-adapted variant of influenza A/FM/1/47 virus is controlled by mutations in genome segments 4, 5, 7, and 8. J Virol. 1990Sep;64(9):4523–33. 2117072
31. Barber MA, Zhang T, Gagne BA, Van Ginderachter JA, De Baetselier P, Sentman CL, Ly49G2 receptor blockade reduces tumor burden in a leukemia model but not in a solid tumor model. Cancer Immunol Immunother. 2008May;57(5):655–62. 17891395
32. Wiltrout RH, Santoni A, Peterson ES, Knott DC, Overton WR, Herberman RB, et al. Reactivity of anti-asialo GM1 serum with tumoricidal and non-tumoricidal mouse macrophages. J Leukoc Biol. 1985May;37(5):597–614. 3884721
33. Trambley J, Bingaman AW, Lin A, Elwood ET, Waitze SY, Ha J, et al. Asialo GM1(+) CD8(+) T cells play a critical role in costimulation blockade-resistant allograft rejection. J Clin Invest. 1999Dec;104(12):1715–22. 10606625
34. Tai LH, Goulet ML, Belanger S, Toyama-Sorimachi N, Fodil-Cornu N, Vidal SM, et al. Positive regulation of plasmacytoid dendritic cell function via Ly49Q recognition of class I MHC. J Exp Med. 2008Dec22;205(13):3187–99. doi: 10.1084/jem.2008071819075287
35. Ely KH, Matsuoka M, DeBerge MP, Ruby JA, Liu J, Schneider MJ, et al. Tissue-protective effects of NKG2A in immune-mediated clearance of virus infection. PLoS One. 2014Sep24;9(9):e108385. doi: 10.1371/journal.pone.010838525251060
36. Perrone LA, Plowden JK, Garcia-Sastre A, Katz JM, Tumpey TM, H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. PLoS Pathog. 2008Aug1;4(8):e1000115. doi: 10.1371/journal.ppat.100011518670648
37. Oldstone MB, Rosen H, Cytokine storm plays a direct role in the morbidity and mortality from influenza virus infection and is chemically treatable with a single sphingosine-1-phosphate agonist molecule. Curr Top Microbiol Immunol. 2014;378:129–47. doi: 10.1007/978-3-319-05879-5_624728596
38. Bermejo-Martin JF, Ortiz de Lejarazu R, Pumarola T, Rello J, Almansa R, Ramirez P, et al. Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza. Crit Care. 2009;13(6):R201. doi: 10.1186/cc820820003352
39. Koh CY, Blazar BR, George T, Welniak LA, Capitini CM, Raziuddin A, et al. Augmentation of antitumor effects by NK cell inhibitory receptor blockade in vitro and in vivo. Blood. 2001May15;97(10):3132–7. 11342440
40. Aranda-Romo S, Garcia-Sepulveda CA, Comas-Garcia A, Lovato-Salas F, Salgado-Bustamante M, Gomez-Gomez A, et al. Killer-cell immunoglobulin-like receptors (KIR) in severe A (H1N1) 2009 influenza infections. Immunogenetics. 2012Sep;64(9):653–62. doi: 10.1007/s00251-012-0623-322652695
41. La D, Czarnecki C, El-Gabalawy H, Kumar A, Meyers AF, Bastien N, et al. Enrichment of variations in KIR3DL1/S1 and KIR2DL2/L3 among H1N1/09 ICU patients: an exploratory study. PLoS One. 2011;6(12):e29200. doi: 10.1371/journal.pone.002920022216211
42. Oldstone MB, Rosen H, Cytokine storm plays a direct role in the morbidity and mortality from influenza virus infection and is chemically treatable with a single sphingosine-1-phosphate agonist molecule. Curr Top Microbiol Immunol. 2014;378:129–47. doi: 10.1007/978-3-319-05879-5_624728596
43. Eichelberger M, Allan W, Zijlstra M, Jaenisch R, Doherty PC, Clearance of influenza virus respiratory infection in mice lacking class I major histocompatibility complex-restricted CD8+ T cells. J Exp Med. 1991Oct1;174(4):875–80. 1919440
44. Denney L, Aitken C, Li CK, Wilson-Davies E, Kok WL, Clelland C, et al. Reduction of natural killer but not effector CD8 T lymphocytes in three consecutive cases of severe/lethal H1N1/09 influenza A virus infection. PLoS One. 2010May18;5(5):e10675. doi: 10.1371/journal.pone.001067520502691